Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2009

Feb 26, 2009

30339_dirs_2009-02-26_d67ad7f4-e0b1-4130-b0bf-00b20f902f83.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-02-24

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-24 Common Stock A 1848.0963 $32.09 Acquired 28852.0885 Direct
2009-02-24 Common Stock A 984 $32.09 Acquired 29836.0885 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-24 Stock Option (Right to Buy) $32.09 A 5500 Acquired 2019-02-24 Common Stock (5500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 419.2193 Indirect
Common Stock 4497.7802 Indirect

Footnotes

F1: Bonus and Incentive shares granted on 2/24/09.

F2: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2006 that have vested for performance period V.

F3: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.